Recruiting
Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease
About this study
With the accelerating global aging population, dementia has become a pressing worldwide issue. This project aims to identify specific plasma biomarkers and ocular indicators for the early detection of Alzheimer's disease (AD).
- Condition
- Alzheimer's Disease (AD)
- Tested
- Multimodal Ophthalmic Imaging and plasma biomarker
- Sponsor
- Peking University First Hospital
Who can join
- Age
- 50 years and older
- Sex
- All sexes
- Healthy volunteers
- Not stated
Inclusion 5
- Minimum age: 50 years
- Study condition: Alzheimer's Disease (AD)
- Male or female participants aged ≥ 50 years;
- Participants diagnosed with Alzheimer's Disease (AD), mild cognitive decline (MCI), subjective cognitive decline (SCD), or cognitively normal (CN);
- Signed informed consent form
Exclusion 3
- Presence of other neurological disorders and systemic diseases that may cause cognitive impairment;
- Inability to cooperate with cognitive assessments;
- Refusal to undergo blood sampling.
Where
1 site, 1 recruiting
Peking University First Hospital
Beijing, China
Potential match only. Final eligibility is determined by the study team.